(BRK.A), (BRK.B)
91Life has acquired Ambucor Health Solutions from Berkshire Hathaway’s Marmon Holdings, significantly expanding its capabilities in cardiac remote monitoring. Ambucor, known for its expertise in monitoring cardiac implanted electronic devices (CIEDs) and wearables, will be integrated into 91Life’s Heart+, a cloud-native platform powered by AI.
Mike Iversen, Chief Commercial Officer at 91Life, emphasized that this acquisition will strengthen their position in the cardiac monitoring industry by offering more advanced AI-driven tools for real-time decision-making. Bleron Baraliu, CEO of 91Life, highlighted their commitment to using AI and big data to revolutionize healthcare, enhancing patient care with innovative and cloud-based solutions.
© 2024 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.